DeNovix releases CellGlow, the instant cell Viability Assay
DeNovix Inc. announces the release of CellGlow, a new ready-to-use viability assay for automated cell counting. CellGlow Viability…
ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation
Background and aims Despite advancements in diagnostic and therapeutic strategies, hepatocellular carcinoma (HCC) remains a leading cause of…